2Suppliers
2Customers
3Debt Items
20Related Chains

HCW Biologics Inc. Suppliers

TickerNameConfidenceEvidence
WUGEN WUGEN 92% The Company entered a development supply agreement with Wugen to provide it with clinical development materials needed for research and clinical development in the first quarter of 2021
INAB IN8bio, Inc. 72% Reciprocal relationship from INAB graph: nt to the UABRF license agreement, see the section titled “Business—Intellectual Property.” Sales and Marketing Given our stage of development, we have not ye…

HCW Biologics Inc. Customers

TickerNameConfidenceEvidence
SQUARE-GATE-CAPITAL-MASTER-FUND-LLC-SERIES-4 SQUARE-GATE-CAPITAL-MASTER-FUND-LLC-SERIES-4 92% Under the Equity Purchase Agreement, the Company will have the right, but not the obligation, to sell to Square Gate, and Square Gate will have the obligation to purchase from the Company, up to $ 20…
INAB IN8bio, Inc. 72% Reciprocal relationship from INAB graph: Reciprocal relationship from HCWB graph: Reciprocal relationship from INAB graph: nt to the UABRF license agreement, see the section titled “Business—Intellec…

HCW Biologics Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
HCWB-DEBT Debt stack $6.8M 90% Market cache reports total debt of $6.8M.
HCWB-DEBT-9996 Warrants outstanding: 2477292 90% xbrl warrant detail from xbrl 2026-03-31.
HCWB-DEBT-9997 Xbrl Convertible 90% xbrl convertible detail from xbrl 2025-06-30.

HCW Biologics Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for HCW Biologics Inc..

HCW Biologics Inc. Ownership

HolderNameConfidenceEvidence
HCWB-OWNER-HRT-FINANCIAL-LP HRT Financial LP 95% 13F/ownership overlay lists HRT Financial LP; shares held 266,393; ownership 3.96%; value $324,999; as of 2026-03-31.
HCWB-OWNER-JANE-STREET-GROUP-LLC Jane Street Group, LLC 95% 13F/ownership overlay lists Jane Street Group, LLC; shares held 14,134; ownership 0.21%; value $4,763; as of 2026-03-31.
HCWB-OWNER-VANGUARD-GROUP-INC Vanguard Group Inc 95% 13F/ownership overlay lists Vanguard Group Inc; shares held 15,426; ownership 0.47%; value $14,818; as of 2025-12-31.
HCWB-OWNER-VIRTU-FINANCIAL-LLC Virtu Financial LLC 95% 13F/ownership overlay lists Virtu Financial LLC; shares held 47,809; ownership 0.71%; value $58,326; as of 2026-03-31.
HCWB-OWNER-SUSQUEHANNA-INTERNATIONAL-GROUP-LLP Susquehanna International Group, LLP 95% 13F/ownership overlay lists Susquehanna International Group, LLP; shares held 20,071; ownership 0.61%; value $19,280; as of 2025-12-31.
HCWB-OWNER-GEODE-CAPITAL-MANAGEMENT-LLC Geode Capital Management, LLC 95% 13F/ownership overlay lists Geode Capital Management, LLC; shares held 14,037; ownership 0.43%; value $13,483; as of 2025-12-31.
HCWB-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC Vanguard Capital Management LLC 95% 13F/ownership overlay lists Vanguard Capital Management LLC; shares held 12,023; ownership 0.18%; value $4,051; as of 2026-03-31.
HCWB-OWNER-CITIGROUP-INC Citigroup Inc. 95% 13F/ownership overlay lists Citigroup Inc.; shares held 10,528; ownership 0.16%; value $3,547; as of 2026-03-31.
HCWB-OWNER-CITADEL-ADVISORS-LLC Citadel Advisors Llc 95% 13F/ownership overlay lists Citadel Advisors Llc; shares held 22,158; ownership 0.68%; value $21,284; as of 2025-12-31.
HCWB-OWNER-UBS-GROUP-AG UBS Group AG 95% 13F/ownership overlay lists UBS Group AG; shares held 1,739; ownership 0.05%; value $1,670; as of 2025-12-31.
HCWB-OWNER-J-W-COLE-ADVISORS-INC J.W. Cole Advisors, Inc. 95% 13F/ownership overlay lists J.W. Cole Advisors, Inc.; shares held 12,500; ownership 0.38%; value $12,007; as of 2025-12-31.
HCWB-OWNER-GOLDEN-STATE-WEALTH-MANAGEMENT-LLC Golden State Wealth Management, Llc 95% 13F/ownership overlay lists Golden State Wealth Management, Llc; shares held 10,000; ownership 0.15%; value $3,370; as of 2026-03-31.
HCWB-OWNER-ARMISTICE-CAPITAL-LLC Armistice Capital, LLC 95% 13F/ownership overlay lists Armistice Capital, LLC; shares held 300,180; ownership 9.15%; value $288,352; as of 2025-12-31.
HCWB-OWNER-TOWER-RESEARCH-CAPITAL-LLC-TRC Tower Research Capital LLC (TRC) 95% 13F/ownership overlay lists Tower Research Capital LLC (TRC); shares held 4,504; ownership 0.14%; value $4,326; as of 2025-12-31.
HCWB-OWNER-DRW-SECURITIES-LLC DRW Securities, LLC 95% 13F/ownership overlay lists DRW Securities, LLC; shares held 35,281; ownership 1.08%; value $33,890; as of 2025-12-31.

HCW Biologics Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
BNRG Brenmiller Energy Ltd 100.00 2
AZN AstraZeneca PLC 100.00 2
BNR Burning Rock Biotech Limited 100.00 2
ALXO ALX Oncology Holdings Inc. 100.00 2
CCEP Coca-Cola Europacific Partners PLC 100.00 2
DSGN Design Therapeutics, Inc. 100.00 2
BLLN BillionToOne, Inc. 100.00 2
BLRX BioLineRx Ltd. 100.00 2
ANIK Anika Therapeutics, Inc. 100.00 2
ANL Adlai Nortye Ltd. 100.00 2
WHWK Whitehawk Therapeutics, Inc. 100.00 2
ANRO Alto Neuroscience, Inc. 100.00 2
AORT Artivion, Inc. 100.00 2
AVBP ArriVent BioPharma, Inc. 100.00 2
CYTOF Altamira Therapeutics Ltd. 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
CYTK Cytokinetics, Incorporated 100.00 2
CTMX CytomX Therapeutics, Inc. 100.00 2
CBIO Crescent Biopharma, Inc. 100.00 2
CSTE Caesarstone Ltd. 100.00 2